Search filters

List of works by Patrizia Mondello

90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityr

scientific article

90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward?

scientific article published on 21 November 2015

A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma.

scientific article

A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies.

scientific article published on 19 September 2017

ABVD vs BEACOPP escalated in Advanced-Stage Hodgkin's Lymphoma: results from a multicenter European study

scientific article published on 17 May 2020

An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules.

scientific article published on 07 December 2016

Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation.

scientific article

Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience

scientific article published on 27 January 2016

BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors

scientific article published on 01 August 2018

Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study

scientific article published on 9 January 2018

Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study

scientific article published on 22 April 2016

Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression.

scientific article published on 12 January 2017

Circulating mitotic figures in a patient with dual infection by Epstein-Barr virus and cytomegalovirus.

scientific article published on 28 June 2013

Cytomegalovirus infections, kidney transplantation, and secondary hemophagocytic lymphohistiocytosis

scientific article published on 15 September 2014

Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma.

scientific article published on 28 January 2017

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study.

scientific article

Emerging drugs for diffuse large B-cell lymphoma

scientific article published on 05 February 2015

Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent

scientific article published in January 2015

Frontline treatment of diffuse large B-cell lymphoma: Beyond R-CHOP

scientific article published on 26 April 2019

Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?

scientific article published on 01 April 2015

Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells.

scientific article published on 28 September 2016

Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?

scientific article published on 5 July 2016

NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death

article published in the Proceedings of the National Academy of Sciences of the United States of America

Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial

scientific article

Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib

scientific article published on 26 November 2018

Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma

scientific article published in 2022

Pim kinases in hematological malignancies: where are we now and where are we going?

scientific article published on 10 December 2014

Primary central nervous system lymphoma: Novel precision therapies

scientific article published on 27 June 2019

Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant disease

scientific article

R-CHOP versus R-COMP: are they really equally effective?

scientific article published on 12 June 2014

Reshaping the therapeutic landscape of chronic lymphocytic leukaemia in the era of targeted therapy

scientific article published on 06 August 2020

Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia.

scientific article published on 9 August 2013

STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphoma

scientific article published on 29 November 2019

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

scientific article published on 08 January 2020

Should the use of surveillance imaging in diffuse large B-cell lymphoma be discontinued?

scientific article published on 23 March 2015

Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features

scientific article published on 09 November 2020

Thyroid function, autoimmunity and nodules in hematological malignancies

scientific article published on 01 June 2015

Paulina is supported by:

About Paulina

Help